Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab
详细信息 查看全文
- 作者：Yara Dadalti Fragosoa ; yara@bsnet.com.br" class="auth_mail" title="E-mail the corresponding author ; Paulo Diniz da Gamab ; Sidney Gomesc ; Jussara Mathias Netto Khourid ; André ; Palma da Cunha Mattae ; Maria Fernanda Mendesf ; Carla Renata Aparecida Vieira Stellag
- 关键词：Dengue fever ; Multiple sclerosis ; Fingolimod ; Natalizumab
- 刊名：Multiple Sclerosis and Related Disorders
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：6
- 期：Complete
- 页码：64-65
- 全文大小：251 K
文摘
- •
Dengue fever is a very prevalent mosquito-borne viral illness in humans.
- •
Blood cell counts may be affected by dengue fever.
- •
There were no complications with concomitant use of fingolimod or natalizumab.
- •
In general, there was no need to alter treatment during dengue fever in the patients.